Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
David M Shaw
Observed names:
D M Shaw,
D Shaw,
D. M. Shaw,
D. Shaw,
D.M Shaw,
D.M. Shaw,
D.Michael Shaw,
David M. SHAW,
David M. Shaw,
David Shaw
show all 10
Observed institutions:
Netherlands Organisation for Applied Scientific Research,
Cancer Research UK,
University of Manchester,
University of Oxford,
London School of Hygiene & Tropical Medicine,
Cancer Research UK Manchester Institute,
The Christie Hospital,
The Christie NHS Foundation Trust
show all 8
OpenAlex ID:
A5044053285
The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors
2005
·
Ryan D Guest
, Robert E Hawkins
, et al.
·
Journal of Immunotherapy
·
335
Heparin and heparan sulfate bind interleukin-10 and modulate its activity
2000
·
Shahram Salek-Ardakani
, John R. Arrand
, et al.
·
Blood
·
149
Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis
1999
·
C.B.M Maassen
, J.D Laman
, et al.
·
Vaccine
·
124
PDF
Engineering the microflora to vaccinate the mucosa: serum immunoglobulin G responses and activated draining cervical lymph nodes following mucosal application of tetanus toxin fragment C‐expressing lactobacilli
2000
·
D. M. Shaw
, B. GaerthÉ
, et al.
·
Immunology
·
122
PDF
Vaccine and antibody-directed T cell tumour immunotherapy
2004
·
Said Dermime
, David E Gilham
, et al.
·
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
·
74
A Novel Strategy To Reduce the Immunogenicity of Biological Therapies
2010
·
Jennifer Somerfield
, Grant A Hill-Cawthorne
, et al.
·
The Journal of Immunology
·
69
Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigen
2001
·
G Forsberg
, L Ohlsson
, et al.
·
British Journal of Cancer
·
64
PDF
Attenuated recombinant vaccinia virus expressing oncofetal antigen (tumor-associated antigen) 5T4 induces active therapy of established tumors.
2002
·
Kate Mulryan
, Matthew G Ryan
, et al.
·
PubMed
·
61
CXCR4 Mediated Chemotaxis Is Regulated by 5T4 Oncofetal Glycoprotein in Mouse Embryonic Cells
2010
·
Thomas D. Southgate
, Owen J. McGinn
, et al.
·
PLoS ONE
·
55
PDF
A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
2007
·
D M Shaw
, N B Connolly
, et al.
·
British Journal of Cancer
·
55
PDF
5T4 Interacts with TIP-2/GIPC, a PDZ Protein, with Implications for Metastasis
2002
·
Abida Awan
, Melinda R. Lucic
, et al.
·
Biochemical and Biophysical Research Communications
·
46
Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization
1993
·
D.Michael Shaw
, Carolynne M. Stanley
, et al.
·
Molecular Immunology
·
38
Functional comparison of annexin V analogues labeled indirectly and directly with iodine-124
2005
·
Bronwen Dekker
, Heather Keen
, et al.
·
Nuclear Medicine and Biology
·
32
Isolation of a high affinity scFv from a monoclonal antibody recognising the oncofoetal antigen 5T4
2000
·
D.M. Shaw
, M.J. Embleton
, et al.
·
Biochimica et Biophysica Acta (BBA) - General Subjects
·
28
Glycosylation and epitope mapping of the 5T4 glycoprotein oncofoetal antigen
2002
·
David M. SHAW
, Andrew M. WOODS
, et al.
·
Biochemical Journal
·
26
PDF
Characterization of the murine 5T4 oncofoetal antigen: a target for immunotherapy in cancer
2002
·
Andrew M. WOODS
, Who W. WANG
, et al.
·
Biochemical Journal
·
23
PDF
The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope.
1995
·
S C Hsu
, D M Shaw
, et al.
·
PubMed Central
·
18
Targeting immune effector molecules to human tumor cells through genetic delivery of 5T4-specific scFv fusion proteins
2002
·
Kevin A Myers
, Matthew G Ryan
, et al.
·
Cancer Gene Therapy
·
16
Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein
1997
·
D Chargelegue
, O.E Obeid
, et al.
·
Immunology Letters
·
8
1099 A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced renal cell carcinoma (RCC)
2003
·
N. Connolly
, D. Shaw
, et al.
·
European Journal of Cancer Supplements
·
4
Peptide-mimics identified from a combinatorial library induce respiratory syncytial virus (RSV) specific neutralising antibody responses and reduce viral load in vivo
1997
·
D. Chargelegue
, O.E. Obeid
, et al.
·
Immunology Letters
·
1
A32 Radiolabelling annexin v with 124I for PET imaging of cell death
2004
·
B. Dekker
, H. Keen
, et al.
·
Nuclear Medicine Communications
A phase II study of ABR-214936 (anatumomab mafenatox) tumour targeted superantigen (TTS) therapy in patients with advanced adenocarcinoma of the pancreas
2004
·
N. B. Connolly
, D. Shaw
, et al.
·
Journal of Clinical Oncology
The Function of Glycosylation in Leucine-rich Repeat (lrr) Protein Receptors
2002
·
David M. Shaw
, Peter Stern
, et al.
·
XXIst International Carbohydrate Symposium 2002
Show more works
View as search
Works count:
26
Citation count:
1,348
H-index:
17
I10-index:
18
Year
Topic
Type
